Home > Events

Events and Conferences

Contact Veristat Now

Request A Proposal

Contact Us

Meet Veristat at BIO-Europe Spring: March 23-25, 2026 - Lisbon, Portugal

March 23, 2026

🔬 Connecting with the Global Biopharma Community

Veristat is pleased to attend BIO-Europe Spring, where biotech innovators, investors, and development leaders come together to form the partnerships that move new therapies forward. As sponsors advance programs through early and mid-stage development, success increasingly depends on disciplined planning, high-quality evidence, and regulatory clarity.

Our team looks forward to meeting with biotech leaders to discuss how Veristat helps sponsors move complex therapies forward while making every dollar of development capital count.

Read More

Meet Veristat at PHUSE US Connect: Advancing Data-Driven Clinical Development

March 18, 2026

🔬 Connecting with the Global Clinical Data and Biostatistics Community

Veristat is pleased to attend PHUSE US Connect 2026, where leaders in biostatistics, statistical programming, data science, and regulatory standards gather to advance innovation in clinical development.

As clinical programs grow more complex and regulatory expectations around data quality continue to evolve, sponsors need statistical leadership and data strategies that transform study data into clear, submission-ready evidence. Events like PHUSE bring together the experts shaping how data standards, analytics, and statistical thinking support better regulatory outcomes.

Our team looks forward to connecting with fellow data and statistical professionals and discussing how strong evidence strategies can support efficient clinical development.

Read More

Veristat Live in China: March 12-20, 2026

March 10, 2026

Meet Veristat at BIOCHINA & CMAC: Advancing Global Clinical Development

🔬 Connecting with the Global Biotech Community

We are pleased to be attending BIOCHINA, where innovators from across the biotech ecosystem come together to discuss the future of drug development and global regulatory strategy. As more companies pursue international pathways for approval, thoughtful clinical planning and strong data strategies have never been more important. Our team looks forward to engaging with fellow leaders, sharing perspectives, and exploring how we can help advance complex therapies from development to regulatory success.

We are also looking forward to attending the CMAC Annual Meeting and spending time with colleagues across the clinical development ecosystem. It’s so valuable to step away from day-to-day program work and have thoughtful conversations about the evolving challenges in trial design, data strategy, and regulatory expectations. So we’re excited to exchange ideas, share perspectives from complex development programs, and connect with teams advancing the next generation of therapies.

Read More

Search

Topics

see all

Follow Us

Monthly Archives

see all
  • Privacy Policy

  • ©2023 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.